基于纹理的影像组学CT分析预测接受立体定向消融放疗的早期非小细胞肺癌患者的结局
本研究开发了一种基于治疗前CT图像二维Riesz小波定量纹理特征的Cox Lasso模型,用于预测接受立体定向消融放疗的早期非小细胞肺癌患者的总生存期。1000次交叉验证的中位log-rank P值为0.030,模型能够根据预测生存期区分患者。将肿瘤大小加入模型后P值失去显著性,而联合实性成分与磨玻璃成分特征时P值改善。
要点
- 治疗前CT的二维Riesz小波纹理特征可区分SABR后NSCLC患者的总生存期(P=0.04)。
- 模型区分生存期时1000次交叉验证的中位log-rank P值为0.030。
- 联合实性成分与磨玻璃成分纹理特征较单用其一P值改善,提示全肿瘤信息重要。
核心结论
- 基于CT二维Riesz小波纹理特征的Cox Lasso模型可能有助于未来研究中利用影像组学特征预测SABR后NSCLC患者的生存结局。
研究设计与样本
- 研究论文;开发基于治疗前CT二维Riesz小波定量纹理特征的Cox Lasso模型,采用1000次交叉验证评估模型区分生存期的能力。
关键影像表现/征象
- 从肿瘤实性成分或磨玻璃成分分别提取Riesz特征建模均保持统计学显著性。
- 联合实性成分与磨玻璃成分特征时P值改善,提示可从整个肿瘤提取重要数据。
诊断标准与关键数值
- 1000次交叉验证的中位log-rank P值为0.030。
- 加入肿瘤大小后模型P值失去显著性。
- CT图像上NSCLC结节的定量影像特征可显著区分患者总生存期(P=0.04)。
临床应用与阅片要点
- 作者认为该模型可能有助于未来研究中利用CT影像组学特征预测SABR后生存结局。
局限性
- 原文指出加入肿瘤大小后P值失去显著性,可能因数据集中事件数相对较少。
- 原文结论使用「may be useful in future studies」限定,未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE:: Stereotactic ablative radiotherapy (SABR) is being increasingly used as a non-invasive treatment for early-stage non-small cell lung cancer (NSCLC). A non-invasive method to estimate treatment outcomes in these patients would be valuable, especially since access to tissue specimens is often difficult in these cases.
METHODS:: We developed a method to predict survival following SABR in NSCLC patients using analysis of quantitative image features on pre-treatment CT images. We developed a Cox Lasso model based on two-dimensional Riesz wavelet quantitative texture features on CT scans with the goal of separating patients based on survival.
RESULTS:: The median log-rank p-value for 1000 cross-validations was 0.030. Our model was able to separate patients based upon predicted survival. When we added tumor size into the model, the p-value lost its significance, demonstrating that tumor size is not a key feature in the model but rather decreases significance likely due to the relatively small number of events in the dataset. Furthermore, running the model using Riesz features extracted either from the solid component of the tumor or from the ground glass opacity (GGO) component of the tumor maintained statistical significance. However, the p-value improved when combining features from the solid and the GGO components, demonstrating that there are important data that can be extracted from the entire tumor.
CONCLUSIONS:: The model predicting patient survival following SABR in NSCLC may be useful in future studies by enabling prediction of survival-based outcomes using radiomics features in CT images.
ADVANCES IN KNOWLEDGE:: Quantitative image features from NSCLC nodules on CT images have been found to significantly separate patient populations based on overall survival (p = 0.04). In the long term, a non-invasive method to estimate treatment outcomes in patients undergoing SABR would be valuable, especially since access to tissue specimens is often difficult in these cases.
引用
- Starkov P, Aguilera TA, Golden DI, et al. The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy. Br J Radiol. 2018. PMID: 30457885. doi:10.1259/bjr.20180228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。